- Home
- UBX vs FGF Comparison
UBX vs FGF Comparison
Compare UBX & FGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- FGF
- Stock Information
- Founded
- UBX 2009
- FGF 2012
- Country
- UBX United States
- FGF United States
- Employees
- UBX N/A
- FGF N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- FGF Property-Casualty Insurers
- Sector
- UBX Health Care
- FGF Finance
- Exchange
- UBX Nasdaq
- FGF Nasdaq
- Market Cap
- UBX 20.4M
- FGF 22.8M
- IPO Year
- UBX 2018
- FGF N/A
- Fundamental
- Price
- UBX $0.99
- FGF $15.87
- Analyst Decision
- UBX Strong Buy
- FGF
- Analyst Count
- UBX 3
- FGF 0
- Target Price
- UBX $5.33
- FGF N/A
- AVG Volume (30 Days)
- UBX 148.7K
- FGF 2.6K
- Earning Date
- UBX 04-22-2025
- FGF 05-19-2025
- Dividend Yield
- UBX N/A
- FGF N/A
- EPS Growth
- UBX N/A
- FGF N/A
- EPS
- UBX N/A
- FGF N/A
- Revenue
- UBX N/A
- FGF $17,348,000.00
- Revenue This Year
- UBX N/A
- FGF N/A
- Revenue Next Year
- UBX N/A
- FGF N/A
- P/E Ratio
- UBX N/A
- FGF N/A
- Revenue Growth
- UBX N/A
- FGF 1.49
- 52 Week Low
- UBX $0.85
- FGF $14.21
- 52 Week High
- UBX $3.10
- FGF $38.40
- Technical
- Relative Strength Index (RSI)
- UBX 37.79
- FGF 34.97
- Support Level
- UBX $0.91
- FGF $15.13
- Resistance Level
- UBX $1.07
- FGF $16.00
- Average True Range (ATR)
- UBX 0.09
- FGF 0.67
- MACD
- UBX 0.03
- FGF -0.07
- Stochastic Oscillator
- UBX 61.29
- FGF 17.80
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About FGF FG Financial Group Inc. (NV)
Fundamental Global Inc through its subsidiaries operates as diversified insurance, reinsurance, and investment management holding company. The company's segment includes Insurance and Asset Management. It generates maximum revenue from the Insurance segment.